CG Stock UPDATES The Carlyle Group L.P. (CG) 29.94 10/22/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
The Carlyle Group L.P. (CG) 29.94 $CG

Global Jet Capital Launches At 2014 NBAA Convention To Serve Long-Range Business Jet Leasing And Financing Market
PR Newswire - Mon Oct 20, 10:00AM CDT
Global Jet Capital, a new company providing leasing and lending solutions for large-cabin, long-range business jets, has officially begun operations. Three global investment firms - GSO Capital Partners, a Blackstone company in partnership with Franklin Square Capital Partners*; The Carlyle Group; and AE Industrial Partners - have partnered to launch the company, which has the financial capacity to fund more than $2 billion in aircraft financing for individual, corporate and government use globally.
CG: 29.94 (+0.95)

KKR Looks to Get More Bang for Its Buck In Strategy Shift
at The Street - Fri Oct 17, 12:46PM CDT
KKR, one of the inventors of modern-day private equity, is trying to move in a new direction by investing larger sums of its own money into buyout deals.
CG: 29.94 (+0.95), BX: 30.72 (+1.31), APO: 23.51 (+0.77), FIG: 6.77 (+0.40), OZM: 11.16 (+0.17), KKR: 21.88 (+0.86)

Private Equity Giants Playing From Strength Despite Selloff
at The Street - Wed Oct 15, 4:00AM CDT
Private equity firms are more disciplined following the financial crisis, so the recent selloff in their shares may be overstated, said Jeff Eaton of Eaton Partners.
CG: 29.94 (+0.95), BX: 30.72 (+1.31), KKR: 21.88 (+0.86)

Kohlberg Kravis Buys Stake in Lemonade Restaurant Group - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 11:00AM CDT
Kohlberg Kravis (KKR) has acquired a minority stake in the Los Angeles-based cafeteria-style chain, Lemonade Restaurant Group.
BAM: 46.56 (+0.86), MRCC: 13.65 (-0.17), CG: 29.94 (+0.95), KKR: 21.88 (+0.86)

Will Blackstone's Strategy to Forego Fees Work in its Favor? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 9:40AM CDT
Blackstone (BX) plans to forego the additional consulting fees it receives at the time of selling or listing its portfolio companies.
CG: 29.94 (+0.95), APO: 23.51 (+0.77), BX: 30.72 (+1.31), KKR: 21.88 (+0.86)

The Carlyle Group Announces Preliminary Third Quarter 2014 Carry Fund Valuations
GlobeNewswire - Mon Oct 06, 5:21PM CDT
Global alternative asset manager The Carlyle Group L.P. (Nasdaq:CG) today released preliminary performance metrics for its carry funds during the third quarter of 2014.
CG: 29.94 (+0.95)

Silver Lake Inches Toward Shutterfly Deal Valued at $2B
at The Street - Thu Sep 25, 10:28AM CDT
Private equity firm is in negotiations to acquire the struggling online photography company as auction's final round ends.
CG: 29.94 (+0.95), SFLY: 42.83 (+0.46), HPQ: 34.74 (+0.92)

Activist Shareholder Peltz Pushes DuPont To Split in Two
at The Street - Wed Sep 17, 9:04AM CDT
The hedge fund investor hints at potential proxy fight as he chides management for excess corporate costs.
CG: 29.94 (+0.95), DD: 68.82 (+1.01), DOW: 48.21 (+1.70)

The Carlyle Group Acquires Postcard Inn Beach Resort at Holiday Isle and La Siesta Resort on Islamorada
PR Newswire - Mon Sep 15, 12:20PM CDT
Global alternative asset manager The Carlyle Group today announced the acquisition of two Florida Keys hotels in Islamorada - the Postcard Inn Beach Resort at Holiday Isle and La Siesta Resort. The two hotels join the Islamorada Resort and Pelican Cove Resort & Marina in Carlyle's Islamorada hotel portfolio. The four properties will form the newly created Islamorada Hotel Company and be managed by Trust Hospitality. Equity for the transactions comes from Carlyle Realty Partners VII, a $2.34 billion U.S. real estate fund.
CG: 29.94 (+0.95)

Allison Transmission CEO selected as recipient of Louis V. Gerstner Jr. Excellence Award
PR Newswire - Fri Sep 12, 6:30AM CDT
Allison Transmission Holdings Inc. (NYSE: ALSN) today announced that Chairman, President and CEO Lawrence E. Dewey has been selected by The Carlyle Group (NASDAQ: CG) as the 2014 recipient of the Louis V. Gerstner Jr. Excellence Award.
CG: 29.94 (+0.95), ALSN: 29.16 (+0.36)

HD Supply Tops Q2 Earnings Estimates On Strong Sales
at Investor's Business Daily - Tue Sep 09, 9:19AM CDT
HD Supply (HDS) topped Wall Street second-quarter earnings and revenue estimates as it continues to flourish since launching its initial public offering in June 2013. HD Supply earnings per share more than doubled to 51 cents from 23 cents in Q2 2013...
CG: 29.94 (+0.95), HD: 94.20 (+2.35), HDS: 26.72 (+1.18)

Drug M&A Boom Driven By Long-Term Trends: PwC
at Investor's Business Daily - Wed Sep 03, 3:22PM CDT
If you've been feeling like drugmaker mergers and acquisitions have been busting out all over the place this year, professional-services firm PricewaterhouseCoopers has the numbers to back you up. In its second-quarter report on the subject, released...
MNK: 89.30 (+2.15), JNJ: 100.36 (+1.16), CG: 29.94 (+0.95), TBPH: 20.67 (-0.05), THRX: 18.64 (+0.69), BMY: 51.95 (+1.39)

Carlyle to Settle LBO Collusion Case for $115M, Avoids Trail - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 11:10AM CDT
Carlyle (CG) was the final private equity firm to settle a lawsuit that accused it of pulling down the prices of LBOs through collusion. The company will be paying a settlement amount of $115 million to avoid going to trail.
CG: 29.94 (+0.95), GS: 180.18 (+2.34), BX: 30.72 (+1.31), KKR: 21.88 (+0.86)

KKR to Acquire 18% of Chinese Meat Producer Sunner for $400M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 10:40AM CDT
Kohlberg Kravis (KKR) announced that it has inked a definitive agreement with Chinese meat producer Fujian Sunner Development Co. Ltd. to buy 18% stake in the latter for around $400 million. The deal is subject to customary approvals.
CG: 29.94 (+0.95), MCD: 91.01 (-0.58), KKR: 21.88 (+0.86), YUM: 69.80 (+0.67)

MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
ABMD: 23.97 (+0.42), BDX: 123.31 (+0.65), MDT: 64.98 (+1.14), ARAY: 7.32 (+0.19), NUVA: 35.73 (+0.44), CYBX: 51.70 (+0.31), BSX: 12.03 (+0.42), JNJ: 100.36 (+1.16), ICUI: 70.19 (+0.04), WMGI: 31.55 (+0.58), OPK: 8.39 (+0.03), RMD: 48.02 (+0.98), ABBV: 56.29 (+1.88), SYK: 82.14 (+1.14), ZMH: 101.32 (+2.13), ABT: 42.39 (+0.93), SMA: 9.82 (+0.21), BCR: 149.22 (+2.50), MCK: 196.93 (+3.84), TMO: 118.22 (+3.89), PFE: 28.28 (+0.35), COV: 89.25 (+3.81), EW: 105.81 (+3.94), MYL: 52.04 (+1.73), COO: 156.55 (+5.25), CG: 29.94 (+0.95), ABAX: 49.36 (+1.11), BAX: 68.65 (+0.71), DGX: 61.12 (+1.47), STJ: 59.99 (+1.03), THOR: 26.51 (+0.25), HGR: 22.05 (-0.22)

MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
ABMD: 23.97 (+0.42), BDX: 123.31 (+0.65), MDT: 64.98 (+1.14), ARAY: 7.32 (+0.19), NUVA: 35.73 (+0.44), CYBX: 51.70 (+0.31), BSX: 12.03 (+0.42), JNJ: 100.36 (+1.16), ICUI: 70.19 (+0.04), WMGI: 31.55 (+0.58), OPK: 8.39 (+0.03), RMD: 48.02 (+0.98), ABBV: 56.29 (+1.88), SYK: 82.14 (+1.14), ZMH: 101.32 (+2.13), ABT: 42.39 (+0.93), SMA: 9.82 (+0.21), BCR: 149.22 (+2.50), MCK: 196.93 (+3.84), TMO: 118.22 (+3.89), PFE: 28.28 (+0.35), COV: 89.25 (+3.81), EW: 105.81 (+3.94), MYL: 52.04 (+1.73), COO: 156.55 (+5.25), CG: 29.94 (+0.95), ABAX: 49.36 (+1.11), BAX: 68.65 (+0.71), DGX: 61.12 (+1.47), STJ: 59.99 (+1.03), THOR: 26.51 (+0.25), HGR: 22.05 (-0.22)

MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews
ABMD: 23.97 (+0.42), BDX: 123.31 (+0.65), MDT: 64.98 (+1.14), ARAY: 7.32 (+0.19), NUVA: 35.73 (+0.44), CYBX: 51.70 (+0.31), BSX: 12.03 (+0.42), JNJ: 100.36 (+1.16), ICUI: 70.19 (+0.04), WMGI: 31.55 (+0.58), OPK: 8.39 (+0.03), RMD: 48.02 (+0.98), ABBV: 56.29 (+1.88), SYK: 82.14 (+1.14), ZMH: 101.32 (+2.13), ABT: 42.39 (+0.93), SMA: 9.82 (+0.21), BCR: 149.22 (+2.50), MCK: 196.93 (+3.84), TMO: 118.22 (+3.89), PFE: 28.28 (+0.35), COV: 89.25 (+3.81), EW: 105.81 (+3.94), MYL: 52.04 (+1.73), COO: 156.55 (+5.25), CG: 29.94 (+0.95), ABAX: 49.36 (+1.11), BAX: 68.65 (+0.71), DGX: 61.12 (+1.47), STJ: 59.99 (+1.03), THOR: 26.51 (+0.25), HGR: 22.05 (-0.22)

NBTY Names Steven Cahillane Chief Executive Officer
PR Newswire - Tue Aug 19, 8:40AM CDT
NBTY, Inc., a global manufacturer, marketer, distributor and retailer of vitamins and nutritional supplements, today named Steven Cahillane Chief Executive Officer. A 25-year consumer goods industry veteran, Mr. Cahillane comes to NBTY from Coca-Cola, where he led the successful integration of Coca-Cola Enterprises' North American bottling operation and drove significant market share gains as President of Coca-Cola Americas. Mr. Cahillane, who succeeds Jeff Nagel, begins his new role on September 8th. NBTY is a portfolio company of The Carlyle Group.
CG: 29.94 (+0.95)

Bank Stock Roundup: JPMorgan & Wells Fargo Remain Busy Restructuring - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 12:01PM CDT
Regulatory investigations on banks remained in place, but active restructuring activities and steps to improve revenues by some of the banks were more prominent in the last five trading days.
CG: 29.94 (+0.95), COF: 78.70 (+2.20), JPM: 57.93 (+1.30), USB: 40.27 (+0.89), C: 51.27 (+0.74), BAC: 16.60 (+0.34), WFC: 50.45 (+1.27), MS: 34.06 (+0.74)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

IONQ Achieves Record Stock Levels Amid Strong Growth Indicators

Updated Category News Views 243

IONQ Stock Reaches New Heights Recently, IONQ has made headlines as its stock skyrocketed to an unprecedented level of $47.41, marking a significant achievement for the company. With a robust market capitalization of $10.2 billion, this remarkable performance is a testament to the company's impressive growth trajectory and the strong belief investors hold in its future....

Continue Reading
Model 1 Commercial Vehicles Expands Leadership Team for Growth

Updated Category News Views 285

Model 1 Commercial Vehicles Announces Leadership Changes Model 1 Commercial Vehicles is thrilled to unveil a set of key leadership appointments aimed at enhancing its strategic direction and ensuring the company's ongoing success. These changes reflect the impressive growth trajectory the company has experienced over the past few years. Tony Matijevich Takes the Helm as...

Continue Reading
Texas Instruments: Unusual Options Trends Uncovered

Updated Category News Views 195

Texas Instruments Options Insights Financial powerhouses have made a notable bullish move on Texas Instruments. Our analysis reveals intriguing trends within the options market for Texas Instruments (NASDAQ: TXN), showcasing an unusual number of trades that pinpoint shifting market sentiments. Trading Sentiment Overview Diving deeper into the data, it appears that 58% of...

Continue Reading
SMCP Unveils Latest Interim Financial Report for 2025

Updated Category News Views 177

SMCP Announces Availability of Its Interim Financial Report SMCP is excited to share that its interim financial report for the six-month period ending June 30, 2025, is now available for public access. This report has been officially filed with the relevant regulatory authorities. Details on the Financial Report This financial report outlines the company's performance...

Continue Reading
Kevin O'Leary Discusses Business Leaders' Support for Trump

Updated Category News Views 159

Understanding O'Leary's Perspective on Business Leadership Kevin O’Leary, a prominent entrepreneur and investor from Shark Tank, has provided insight into the evolving relationship between business leaders and President Trump. In recent discussions, O’Leary emphasized that the admiration many tech CEOs and corporate leaders have for Trump is not solely about his tax...

Continue Reading